Study design and participants
deafness, bleeding, mental disabilities, labor pain, Cephalopelvic disproportion, diabetes
BLEEDING, GROWTH DISORDER, CHRONIC DISEASES, DISORDERS, UTERUS, SECONDARY, PLACENTA PREVIA, HYPERTENSION, PLACENTAL ABRUPTION, HIGH-RISK PREGNANCY, DIABETES
This two-arm randomized controlled clinical trial was conducted on 64 primiparous women referred to the perinatology clinic of Taleghani educational-treatment hospital, affiliated to Tabriz University of Medical sciences, Iran, from March 2022 to June 2022. The primigravida women with a gestational age of 32—34 weeks and a cephalic singleton pregnancy and without mental disabilities or deafness who intended to give birth in the afore-mentioned hospitals participated in the study. The exclusion criteria included a history of mental disorders before pregnancy based on the health proflie, abnormal volume of amniotic fluid, having any surgery on the uterus, non-reactive NST, fetal abnormality, high-risk pregnancy, including hypertension, diabetes, placenta previa, and cardiovascular and other chronic diseases, bleeding in the third trimester, placental abruption, fetal growth disorder, pregnancy with the assisted reproductive technologies, the desire to receive other pharmacological and non-pharmacological analgesia methods, unplanned pregnancy, any contraindications for vaginal delivery, including Cephalopelvic disproportion (CPD).This study was part of a master’s thesis, investigating the effect of mindfulness-based counseling on the experience, support, and control of childbirth as a primary outcome and labor pain and fear as a secondary outcome.